◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

ACUTUS MEDICAL, INC.

CIK: 1522860 SIC: 3841 CARLSBAD, CA
Loading stock data...
Key Financial Metrics (TTM | FY 2024)
$20.15M
Revenue
$-9.55M
Net Income
-0.33
EPS (Diluted)
$-72.85M
Free Cash Flow
Profitability
Gross Margin 4.98%
Operating Margin -0.33%
Net Profit Margin -47.38%
EBITDA $-66.00K
Returns & Efficiency
Return on Assets (ROA) -33.33%
Return on Equity (ROE) -
Gross Profit $1.00M
Operating Income $-66.00K
Financial Health
Total Assets $28.65M
Total Debt $25.56M
Debt to Equity -x
Current Ratio 2.06
Debt Analysis
Debt to EBITDA -
Debt to Free Cash Flow -
Cash & Equivalents -
Net Debt -
Capital Returns
Return on Invested Capital (ROIC) -
Invested Capital -
Stockholders Equity -
Revenue Growth -
Market Valuation
Market Cap -
P/E Ratio -
Price to Book -
EPS (Diluted) $-0.33
Quick Access Filings
10-K
Annual Report

Loading...

10-Q
Quarterly Report

Loading...

8-K
Recent News

Loading...

Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral Open Market Buys: - Open Market Sales: - Option Exercise & Sale: - Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral 0 Buys $0 0 Sales $0 0 Exercises $0 Net: $0
Insider Title Date Type Shares Price Value
Company Information
Business Address 2210 FARADAY AVE
SUITE 100
CARLSBAD, CA 92008
Phone 442-232-6080
Incorporated DE, US
EIN 451306615
Fiscal Year End 1231
Stockholders' Equity $-11.59M
Cash & Equivalents $14.02M
Recent Filings View All
SCHEDULE 13G/A Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-17
Local
10-K Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-03-24
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-14
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-08
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-09
Local
DEF 14A Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-04-25
Local
10-K Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-04-01
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-11-14
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-08-07
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-05-11
Local
DEF 14A Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2023-04-27
Local
10-K Annual Report
Comprehensive annual financial report with audited statements
Filed: 2023-03-24
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2022-11-10
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2022-08-11
Local
10-Q Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2022-05-12
Local
Financial Statistics
Valuation
Market Cap -
P/E Ratio (TTM) -
Price to Book -
EV/Revenue -
EV/EBITDA -
Profitability
Gross Margin 5.0%
Operating Margin -0.3%
Net Margin -47.4%
ROE -
ROA -33.3%
Leverage & Liquidity
Debt to Equity -
Current Ratio 2.06
Total Debt $25.56M
Total Assets $28.65M
Stockholders' Equity $-11.59M
Income Statement (FY 2024)
Revenue $20.15M
Gross Profit $1.00M
Operating Income $-66.00K
Net Income $-9.55M
EPS (Diluted) $-0.33
Cash Flow (FY 2024)
Free Cash Flow $-72.85M
Cash & Equivalents $14.02M
Revenue Growth -0.0%
Loading...

Loading management data...

Loading...

Loading board of directors...

Loading...

Loading institutional holders...

NEWS
Loading news...
TRENDING
Loading...